SUBSCRIBE
SUBSCRIBE

IPO

Deals
Zai Lab Completes $150 Million IPO; Stock Jumps 50% At Opening; Company Worth $1.4 Billion
September 20, 2017
 · 
1 min read
Deals
OptiNose Files for $100 Million IPO
September 19, 2017
 · 
1 min read
Deals
Massachusetts’ Deciphera Seeks $100 Million IPO
September 19, 2017
 · 
1 min read
Deals
Boston Rare Disease Biopharma Rhythm Seeks $115 Million IPO
September 6, 2017
 · 
1 min read
Deals
SoCal’s RA Medical Exec Aims for IPO
September 1, 2017
 · 
1 min read
Biotech Bay
The Best And Worst Biotech IPOs Of 2017
August 23, 2017
 · 
1 min read
3 Biotechs That Could be Taken Out This Quarter
Deals
Gene Therapy Firm Krystal Biotech Files for $35 Million IPO
August 22, 2017
 · 
2 min read
3 Biotechs That Could be Taken Out This Quarter
Deals
Former Pfizer Scientist-Led Startup Zai Lab Taps Banks for $150M IPO
August 11, 2017
 · 
3 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Deals
Clementia to Launch IPO, Despite So-So Phase II Trials and Investor Skepticism
August 1, 2017
 · 
2 min read
Deals
Tiny Bob Langer-Backed Kite Pharma Files For $86 Million IPO
June 27, 2017
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
HanchorBio Prices IPO at NT$120 Ahead of Innovation Board Listing on May 29
May 26, 2026
 · 
3 min read
Press Releases
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX)
May 22, 2026
 · 
6 min read
Press Releases
InMed Pharmaceuticals Amends Preferred Investment Options
May 19, 2026
 · 
1 min read
Press Releases
Mobia Medical Announces Pricing of Initial Public Offering
May 8, 2026
 · 
2 min read
Press Releases
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
May 8, 2026
 · 
4 min read
Press Releases
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
 · 
2 min read
Press Releases
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
 · 
2 min read
Press Releases
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
 · 
4 min read
Press Releases
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
 · 
4 min read
Press Releases
Avalyn Announces Pricing of Upsized Initial Public Offering
April 29, 2026
 · 
4 min read
Press Releases
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 21, 2026
 · 
2 min read
Press Releases
Kailera Therapeutics Announces Pricing of Initial Public Offering
April 17, 2026
 · 
2 min read
Press Releases
Integrant Awarded Nasdaq Ticker “INGT” Ahead of Highly Anticipated IPO
April 16, 2026
 · 
2 min read
Press Releases
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
April 10, 2026
 · 
5 min read
Press Releases
Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading
March 31, 2026
 · 
3 min read
Press Releases
Theralase(R) Closes $1.1 M Non-Brokered Private Placement
March 10, 2026
 · 
1 min read
Press Releases
MiniMed announces pricing of initial public offering - March 5, 2026
March 5, 2026
 · 
5 min read
Press Releases
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
February 27, 2026
 · 
3 min read
Press Releases
MiniMed announces launch of IPO roadshow
February 24, 2026
 · 
6 min read
Press Releases
Agomab Announces Closing of Initial Public Offering
February 10, 2026
 · 
4 min read
Load More